LANREOTIDE- lanreotide powder
Bachem Americas, Inc.
| LANREOTIDE |
|Product Information |
|Product Type ||BULK INGREDIENT ||Item Code (Source) ||NHRIC:52416-117 |
|Route of Administration ||NOT APPLICABLE ||DEA Schedule || |
|Active Ingredient/Active Moiety |
|Ingredient Name ||Basis of Strength ||Strength |
|LANREOTIDE (LANREOTIDE) ||LANREOTIDE ||1 g in 1 g |
|# ||Item Code ||Package Description ||Multilevel Packaging |
| 1 ||NHRIC:52416-117-01 ||300 g in 1 BOTTLE, GLASS ||None |
| Marketing Information |
|Marketing Category ||Application Number or Monograph Citation ||Marketing Start Date ||Marketing End Date |
|Export only || ||11/17/2014 || |
|Labeler — Bachem Americas, Inc.
Revised: 10/2020 Bachem Americas, Inc.
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.